{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:00Z","timestamp":1793039340408,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cases of SCH associated with PPV excluding trauma were retrospectively analyzed in Beijing Tongren Hospital between January 2010 and June 2020. The data collected included general data, myopia status, axial length, state of the crystalline lens, SCH onset time, range, treatment method, visual prognosis, and methods of operation and anesthesia. Patients were divided into those with SCH related to the first PPV (Group 1), and SCH related to second intraocular surgery in the vitrectomized eye (Group 2). Patients were also classified by the SCH onset time into either the expulsive suprachoroidal hemorrhage group (ESCH) and the delayed suprachoroidal hemorrhage group (DSCH). The general data, related risk factors, and the visual prognosis of SCH in the different groups were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SCH associated with PPV was studied in 28 cases with an incidence of 0.06\u2009%; 16 males and 12 females. The mean age of the patients was (53.51\u2009\u00b1\u200910.21) years old, the mean follow-up time was (24.94\u2009\u00b1\u200914.60) days, and the mean axial length was (28.21\u2009\u00b1\u20093.14) mm. Of these cases, 21 were classified as high myopia, 25 as aphakia\/ pseudophakic, and 7 as focal hemorrhage. Silicone oil removal occurred in 12 cases (43\u2009%). Patients in Group 2 were younger than Group 1 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005). In terms of treatment and prognosis, 5 eyes were simply closely observed, 4 were given single suprachoroidal drainage, 15 were given suprachoroidal drainage combined with silicone tamponade, 2 underwent anterior chamber puncture, and 2 gave up treatment. A follow-up vision: NLP\u2009~\u200920\/30; among them, 2 eyes with NLP (7.14\u2009%), 6 of \u2265\u200920\/200 (21.43\u2009%). The final outcomes presented a significantly positive correlation with baseline vision but no significant correlation with age or axial length.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SCH has a higher incidence rate after a second intraocular surgery in a vitrectomized eye which is associated with the lack of vitreous support and easier fluctuation of intraocular pressure. SCH associated with PPV is more localized and has a relatively good prognosis; high myopia and aphakic\/ pseudophakic eyes are risk factors. Active treatment can effectively improve visual prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Retrospective case series study, not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-021-02062-7","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T04:03:11Z","timestamp":1628654591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suprachoroidal hemorrhage associated with pars plana vitrectomy"],"prefix":"10.1186","volume":"21","author":[{"given":"Bin","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"issue":"6","key":"2062_CR1","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ajo.2004.07.002","volume":"138","author":"DM Moshfeghi","year":"2004","unstructured":"Moshfeghi DM, Kim BY, Kaiser PK, Sears JE, Smith SD. Appositional suprachoroidal hemorrhage: a case-control study. Am J Ophthalmol. 2004;138(6):959\u201363.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"2062_CR2","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/S0161-6420(01)00763-1","volume":"108","author":"SS Tuli","year":"2001","unstructured":"Tuli SS, WuDunn D, Ciulla TA, Cantor LB. Delayed suprachoroidal hemorrhage after glaucoma filtration procedures. Ophthalmology. 2001;108(10):1808\u201311.","journal-title":"Ophthalmology"},{"issue":"4","key":"2062_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0161-6420(93)31621-0","volume":"100","author":"MG Reynolds","year":"1993","unstructured":"Reynolds MG, Haimovici R, Flynn HW, Dibernardo C, Byrne SF, Feuer W. Suprachoroidal hemorrhage: clinical features and results of secondary surgical management. Ophthalmology. 1993;100(4):460\u20135.","journal-title":"Ophthalmology"},{"issue":"8","key":"2062_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1755-3768.2008.01266.x","volume":"86","author":"LC Wang","year":"2008","unstructured":"Wang LC, Yang CM, Yang CH, Huang JS, Ho TZ, Lin CP, Chen MS. Clinical characteristics and visual outcome of non-traumatic suprachoroidal haemorrhage in Taiwan. Acta Ophthalmol. 2008;86(8):908\u201312.","journal-title":"Acta Ophthalmol"},{"key":"2062_CR5","unstructured":"Sukpen I, Stewart JM. Acute intraoperative suprachoroidal hemorrhage during small-gauge pars plana vitrectomy. Retinal Cases Brief Rep. 2018;12:suppl1,S9\u201311."},{"issue":"5","key":"2062_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0021-5155(00)00241-0","volume":"44","author":"M Ishida","year":"2000","unstructured":"Ishida M, Takeuchi S. Vitrectomy for the treatment of expulsive hemorrhage. Jpn J Ophthalmol. 2000;44(5):571.","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"2062_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0161-6420(78)35637-2","volume":"85","author":"R Machemer","year":"1978","unstructured":"Machemer R, Laqua H. A logical approach to the treatment of massive periretinal proliferation. Ophthalmology. 1978;85(6):584\u201393.","journal-title":"Ophthalmology"},{"issue":"6","key":"2062_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.ajo.2015.08.035","volume":"160","author":"M Reibaldi","year":"2015","unstructured":"Reibaldi M, Longo A, Romano MR, Cennamo G, Mariotti C, Boscia F, Bonfiglio V, Avitabile T. Delayed suprachoroidal hemorrhage after pars plana vitrectomy: five-year results of a retrospective multicenter cohort study. Am J Ophthalmol. 2015;160(6):1235\u201342.","journal-title":"Am J Ophthalmol"},{"key":"2062_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ajo.2018.07.027","volume":"195","author":"SW Ch\u2019ng","year":"2018","unstructured":"Ch\u2019ng SW, Patton N, Ahmed M, Ivanova T, Baumann C, Charles S, Jalil A. The Manchester Large Macular Hole Study: Is it time to reclassify large macular holes? Am J Ophthalmol. 2018;195:36\u201342.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2062_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0161-6420(99)90062-3","volume":"106","author":"H Tabandeh","year":"1999","unstructured":"Tabandeh H, Sullivan PM, Smahliuk P, Flynn HW, Schiffman J. Suprachoroidal hemorrhage during pars plana vitrectomy risk factors and outcomes. Ophthalmology. 1999;106(2):236\u201342.","journal-title":"Ophthalmology"},{"issue":"9","key":"2062_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.oret.2018.01.009","volume":"2","author":"Y Iwama","year":"2018","unstructured":"Iwama Y, Nakashima H, Emi K, Bando H, Ikeda T. Influence of surgical procedures and instruments on the incidence of suprachoroidal hemorrhage during 25-gauge pars plana vitrectomy. Ophthalmol Retina. 2018;2(9):888\u201394.","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"2062_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00417-013-2550-x","volume":"252","author":"W Jin","year":"2014","unstructured":"Jin W, Xing Y, Xu Y, Wang W, Yang A. Management of delayed suprachoroidal haemorrhage after intraocular surgery and trauma. Grafes Arch Clin Exp Ophthalmol. 2014;252(8):1189\u201393.","journal-title":"Grafes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2062_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ophtha.2013.06.021","volume":"121","author":"A Chandra","year":"2014","unstructured":"Chandra A, Xing W, Kadhim MR, Williamson TH. Suprachoroidal hemorrhage in pars plana vitrectomy: risk factors and outcomes over 10 years. Ophthalmology. 2014;121(1):311\u20137.","journal-title":"Ophthalmology"},{"issue":"3","key":"2062_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00055735-200106000-00006","volume":"12","author":"H Tabandeh","year":"2001","unstructured":"Tabandeh H, Flynn HW. Suprachoroidal hemorrhage during pars plana vitrectomy. Curr Opin Ophthalmol. 2001;12(3):179\u201385.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"2062_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.mehy.2015.07.009","volume":"85","author":"Y Huang","year":"2015","unstructured":"Huang Y, Liao Q, Yuan R. Management and visual outcome of SCH in Vitrectomized eye. Med Hypotheses. 2015;85(5):548\u201350.","journal-title":"Med Hypotheses"},{"issue":"3","key":"2062_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2298\/VSP1503287V","volume":"72","author":"D Vukovi\u0107","year":"2015","unstructured":"Vukovi\u0107 D, Petrovi\u0107 S, Paovi\u0107 P. Secondary surgical management of suprachoroidal hemorrhage during pars plana vitrectomy. Vojnosanit Pregl. 2015;72(3):287\u201390.","journal-title":"Vojnosanit Pregl"},{"issue":"2","key":"2062_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000027295","volume":"212","author":"OW Kwon","year":"1998","unstructured":"Kwon OW, Kang SJ, Lee JB, Lee SC, Yoon YD, Oh JH. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator. Ophthalmologica. 1998;212(2):120\u20135.","journal-title":"Ophthalmologica"},{"issue":"1","key":"2062_CR18","first-page":"170","volume":"11","author":"P Fei","year":"2018","unstructured":"Fei P, Jin HY, Zhang Q, Li X, Zhao PQ. Tissue plasminogen activator-assisted vitrectomy in the early treatment of acute massive suprachoroidal hemorrhage complicating cataract surgery. Int J Ophthalmol. 2018;11(1):170\u20131.","journal-title":"Int J Ophthalmol"},{"key":"2062_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/OPTH.S16134","volume":"5","author":"N Kunjukunju","year":"2011","unstructured":"Kunjukunju N, Gonzales CR, Rodden WS. Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage. Clin Ophthalmol. 2011;5:155\u20137.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"2062_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000342136","volume":"3","author":"K Matsumoto","year":"2012","unstructured":"Matsumoto K, Matsumoto CS, Shinoda K, Watanabe E, Mizota A. Tissue plasminogen activator-assisted vitrectomy for ruptured eye with suprachoroidal hemorrhage. Case Rep Ophthalmol. 2012;3(2):258\u201361.","journal-title":"Case Rep Ophthalmol"},{"issue":"4","key":"2062_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10384-011-0032-4","volume":"55","author":"T Murata","year":"2011","unstructured":"Murata T, Kikushima W, Imai A, Toriyama Y, Tokimitsu M, Kurokawa T. Tissue-type plasminogen activator-assisted drainage of suprachoroidal hemorrhage showing a kissing configuration. Jpn J Ophthalmol. 2011;55(4):431\u20132.","journal-title":"Jpn J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02062-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T04:07:07Z","timestamp":1628654827000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02062-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-244449\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Beijing Tongren Hospital. Due to the retrospective nature of this study, the inform consent from individual patient was waived by the Ethical Committee of the Beijing Tongren Hospital in this study. This study complied with the guidelines of the Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}